Clinical Trials Logo

Clinical Trial Summary

Malignant tumor patients are at high risk of medical adhesive-related skin injury(MARSI).MARSI can cause local skin ulceration, increase the difficulty of fixation and maintenance frequency, even cause unplanned extubation, and increase the pain and economic burden of the patient's re-installation.Malignant tumor patients with long-term PICC are prone to MARSI.CaviionTM can form a protective film on the skin.Applying CaviionTM before using the adhesive can effectively protect the skin and reduce the occurrence of rash.In China, CaviionTM is mostly used in infants and young children, but adults lack corresponding report and application data.Therefore, it is necessary to carry out corresponding randomized controlled study on adult patients, especially malignant tumors


Clinical Trial Description

The incidence of medical viscose-related skin injury after PICC intubation is as high as 33.15%. The main types of injury are mechanical injury, moisture-related skin injury, contact dermatitis 8.02%, folliculitis.After radiotherapy and chemotherapy, patients with malignant tumors interfere with the formation of new damaged skin cells.Large doses of immunosuppressive agents further weaken the skin barrier and are prone to skin metabolism and immune function disorder.In this study, patients with malignant tumor after PICC intubation were randomly assigned.The experimental group uses CaviionTM, and the control group does not use CaviionTM. Observe the skin condition one month after the tube placement ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05776732
Study type Interventional
Source Second Affiliated Hospital, School of Medicine, Zhejiang University
Contact
Status Active, not recruiting
Phase N/A
Start date March 7, 2022
Completion date December 30, 2023

See also
  Status Clinical Trial Phase
Active, not recruiting NCT02261415 - The HeLiX (Hemorrhage During Liver Resection: traneXamic Acid) Trial Phase 3
Recruiting NCT06450145 - Evaluate the Efficacy and Safety of Interferon-α Combined With ATO in the Treatment of Arsenic-resistant APL N/A
Completed NCT01651182 - Tranexamic Acid Versus Placebo for Blood to Reduce Perioperative Bleeding Post-liver Resection Phase 3
Not yet recruiting NCT06205888 - To Compare the Clinical Application of 18F-LNC1007 Injection PET/CT and 18F-FDG PET/CT
Completed NCT03920371 - Evaluation of a Prototype Hand Held Hybrid Gamma Camera N/A
Completed NCT03146624 - Evaluation of Patients Satisfaction of Attachment Retained Versus Clasp Retained Obturators in Unilateral Total Maxillectomy N/A
Recruiting NCT05779514 - Effect of Mirabegron on Promoting Brown Adipose Tissue Activation N/A